Inhibition of CD146 gene expression via RNA interference reduces in vitro perineural invasion on ACC-M cell

W Chen1, H L Zhang, Y G Jiang

  • 1Department of Oral and Maxillofacial Surgery, Fourth Military Medical University, Shaanxi, China.

Abstract

Insights

Melanoma cell adhesion molecule (MCAM) knockdown inhibits adenoid cystic carcinoma (ACC) cell growth and perineural invasion. Targeting CD146 may be a therapeutic strategy for ACC progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Melanoma cell adhesion molecule (MCAM), also known as CD146, is an immunoglobulin superfamily member.
  • MCAM/CD146 overexpression is linked to enhanced invasion, metastasis, growth, and survival in malignant cells.

Purpose of the Study:

  • To investigate the role of CD146 in adenoid cystic carcinoma (ACC) using RNA interference.
  • To assess the impact of CD146 gene silencing on ACC cell proliferation, cell cycle, and perineural invasion (PNI).

Main Methods:

  • Utilized a human U6 promoter-driven DNA template for short hairpin RNA (shRNA)-mediated CD146 gene silencing in ACC-M cells.
  • Employed reverse transcription-polymerase chain reaction (RT-PCR) and Western blot to confirm CD146 knockdown.
  • Assessed cell proliferation (MTT assay), cell cycle distribution (flow cytometry), and in vitro PNI activity.

Main Results:

  • Specific shRNAs effectively reduced CD146 transcription and protein levels in ACC-M cells.
  • CD146 knockdown inhibited ACC cell proliferation and induced G0/G1 to S phase arrest.
  • Silencing CD146 significantly decreased the in vitro PNI activity of ACC-M cells.

Conclusions:

  • CD146 is implicated as an ACC-related gene.
  • CD146 plays a crucial role in ACC carcinogenesis, progression, and perineural invasion.
  • Targeting CD146 presents a potential therapeutic avenue for managing ACC.